Artificial pancreas therapy to steady sugars and protect the heart
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes for at least 1 year
- You use insulin now (at least 6 months), and you’ll use only Humalog or Novolog during the study
- You’re age 18 to 40, with A1c below 10.5% and body mass index between 18 and 30
- Your blood pressure is below 140/90, and you can check/upload diabetes data as the study requests
- If you can get pregnant, you must not be pregnant and agree to reliable birth control during the study
- You’re willing to pause any personal continuous glucose monitor once the study monitor is started
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests whether using an automated insulin delivery system (a smart pump that adjusts insulin based on sensor readings) can help improve blood sugar control and bone health in adults with Type 1 diabetes who have high and unstable blood sugars.
This trial tests whether an automated insulin delivery system (artificial pancreas) can help people recently diagnosed with type 1 diabetes manage their blood sugar better. The goal is to see if early use of this technology can preserve the body's ability to make some insulin.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.